Syngene International Limited
Status: Publicly traded
Direct answer
Syngene International Limited is publicly traded on NSE under the ticker SYNGENE.NS.
Syngene International Limited, an India-based contract research and manufacturing organization (CRAMO), offers a wide array of drug discovery and development solutions to clients across India, the United States, and other international markets. The company's comprehensive service portfolio begins with discovery chemistry, encompassing medicinal and synthetic chemistry, library and peptide synthesis, biomolecule...
Can you invest in Syngene International Limited?
Yes. Syngene International Limited is publicly traded on NSE under the ticker SYNGENE.NS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Syngene International Limited
Detailed equity research is provided by MarketSnap.